Hansen’s disease is the medical name for leprosy, a chronic infection caused by slow-growing bacteria that primarily damage the skin and peripheral nerves. It affects roughly 173,000 people worldwide each year, and while it carries centuries of stigma, it is curable with a combination of antibiotics typically taken for one to two years.
What Causes Hansen’s Disease
Two related bacteria are responsible: Mycobacterium leprae and Mycobacterium lepromatosis. Both grow extraordinarily slowly compared to most infectious bacteria, which is why the disease can take years to produce noticeable symptoms. The bacteria have a strong preference for certain tissues, particularly skin cells, the lining of the nose, and the protective sheaths around peripheral nerves in the hands, feet, and face.
This nerve targeting is what makes Hansen’s disease distinct from most other infections. As the bacteria multiply inside nerve cells, they trigger inflammation that gradually damages the nerve fibers themselves. Left untreated, this leads to loss of sensation, muscle weakness, and the kind of visible deformities historically associated with leprosy.
How It Spreads
Transmission is not fully understood, but the two most accepted routes are respiratory droplets and broken skin contact. When someone with untreated Hansen’s disease coughs or sneezes, they can release aerosol droplets containing the bacteria. Close, prolonged contact with an untreated person raises the risk compared to the general population, but casual or brief interactions are very unlikely to transmit the infection.
The disease is far less contagious than most people assume. About 95% of the human population has a natural immune resistance to M. leprae, meaning even with exposure, the vast majority of people will never develop symptoms. The combination of low contagiousness and effective treatment means that people receiving antibiotics quickly become noninfectious.
Early Signs and Symptoms
Because the bacteria grow so slowly, the incubation period is unusually long, often ranging from three to five years and sometimes stretching beyond a decade. When symptoms do appear, they tend to start subtly. The hallmark early signs include:
- Skin lesions: One or more patches on the skin that may be lighter or darker than surrounding tissue, either flat or slightly raised. These patches often feel numb to touch, temperature, or pain.
- Thickened nerves: Peripheral nerves near the skin surface, particularly around the elbows, wrists, and knees, can become noticeably enlarged and sometimes tender.
- Sensory loss: Numbness or tingling in the hands or feet that gradually worsens over time.
As the disease progresses, it can cause swelling in the hands and feet, weakness in the muscles controlled by affected nerves, and acute flare-ups of inflammation in existing skin patches. In advanced cases, the eyes and the lining of the nose can also be affected, potentially leading to vision problems and chronic nasal congestion or nosebleeds.
Two Main Forms of the Disease
Doctors classify Hansen’s disease into two broad categories that determine how it is treated. Paucibacillary (PB) Hansen’s disease involves fewer skin lesions and a lower bacterial load. The immune system is doing a reasonable job containing the infection, so nerve damage tends to be more localized. Multibacillary (MB) Hansen’s disease involves widespread skin involvement, more bacteria present in the body, and a higher risk of progressive nerve damage across multiple areas.
The distinction matters because it dictates which drug combination you receive and for how long. A skin or nerve biopsy, sometimes combined with a skin smear, helps doctors determine which form is present. The biopsy tissue is stained to reveal the bacteria under a microscope. In cases where the diagnosis is unclear, genetic testing (PCR) on the biopsy sample can detect bacterial DNA and provide supporting evidence, particularly in early or low-bacteria cases.
How Hansen’s Disease Is Treated
Treatment relies on multi-drug therapy, a combination of antibiotics that attack the bacteria through different mechanisms to prevent resistance. The standard regimen recommended by the World Health Organization includes dapsone, rifampicin, and clofazimine. For paucibacillary cases, treatment typically lasts about one year. Multibacillary cases usually require two years of therapy.
Starting treatment early is critical. Antibiotics kill the bacteria and halt further nerve damage, but they cannot reverse damage that has already occurred. Someone diagnosed before significant nerve involvement can expect a full recovery with no lasting disability. Someone diagnosed late may retain permanent numbness, muscle weakness, or visible changes in the hands and feet even after the infection is cured. This is why recognizing the early signs, particularly numb skin patches, matters so much.
During treatment, some people experience immune reactions where the body’s inflammatory response to dying bacteria causes sudden flare-ups of pain, swelling, or new skin nodules. These reactions are manageable with additional medications but can be uncomfortable and sometimes require close monitoring.
Where Hansen’s Disease Still Occurs
Globally, about 173,000 new cases are reported each year. The burden is concentrated in a handful of countries. India alone accounts for roughly 101,000 new cases annually, followed by Brazil with about 22,000 and Indonesia with nearly 15,000. Several countries in sub-Saharan Africa and South Asia report between 1,000 and 3,000 cases per year, including the Democratic Republic of the Congo, Mozambique, Ethiopia, and Nepal.
In the United States, Hansen’s disease is rare but not absent. Between 2013 and 2022, the country reported 124 to 216 cases per year. Most of these occurred in people who had spent time in regions where the disease is more common, though a small number of states do see locally acquired cases. The National Hansen’s Disease Program, based in Baton Rouge, Louisiana, serves as the primary U.S. referral center for diagnosis and treatment.
Long-Term Nerve Damage and Disability
The most serious consequence of Hansen’s disease is peripheral nerve destruction. When nerves in the hands and feet lose function, you lose the ability to feel pain in those areas. This might sound minor, but pain is a protective signal. Without it, small injuries like burns, cuts, and blisters go unnoticed, leading to repeated trauma and secondary infections that can eventually cause tissue loss.
Muscle weakness from damaged motor nerves can cause the fingers or toes to curl into fixed positions over time. Facial nerve involvement can prevent the eyelids from closing fully, drying out the cornea and threatening vision. Nasal cartilage can collapse if the lining of the nose is heavily affected. All of these complications are preventable with timely diagnosis and treatment, which is why the modern medical focus is on early detection and reducing the diagnostic delay that still occurs in many parts of the world.
For people who do have lasting nerve damage after treatment, rehabilitation strategies like protective footwear, physical therapy, and reconstructive surgery can significantly improve daily function and quality of life.